Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/68493
Title: | Inappropriate prescribing to older patients admitted to hospital: A comparison of different tools of misprescribing and underprescribing |
Author: | San José, Antonio Agustí, Antonia Vidal, Xavier Formiga Pérez, Francesc López-Soto, Alfonso Fernández Moyano, Antonio García, Juana Ramírez Duque, Nieves Torres, Olga H. Barbé, José |
Keywords: | Prescripció de medicaments Malalties de les persones grans Administració de medicaments Drug prescribing Older people diseases Administration of drugs |
Issue Date: | 29-Aug-2014 |
Publisher: | Elsevier B.V. |
Abstract: | Purpose: This study aims to assess inappropriate prescribing (IP) to elderly patients during the month prior to hospitalization and to compare different IP criteria. Methods: An observational, prospective and multicentric study was carried out in the internal medicine services of seven Spanish hospitals. Patients aged 75 years and older were randomly selected after hospital admission for a year. To assess potentially inappropriate medicines (PIMs), the Beers and STOPP criteria were used and to assess Potentially Prescribing Omissions (PPOs), the START criteria and ACOVE-3 medicine quality indicators were used. An analysis to assess factors associated with IP was performed. Results: 672 patients [median age (Q1_Q3) 82 (79-86) years, 55.9% female] were included. Median prescribed medicines in the month prior to hospitalization were 10(Q1-Q3 7-13). The prevalence of IP was 87.6%, and 54.3% of patients had PIMs and PPOs concurrently. A higher prevalence rate of PIMs was predicted using the STOPP criteria than with the Beers criteria (p<.001) and a higher prevalence of PPOs using the ACOVE-3 criteria than using the START criteria (p<.001) was observed. Polypharmacy (≥10 medicines) was the strongest predictor of IP [OR=11.34 95% confidence interval (CI) 4.96-25.94], PIMs [OR=14.16, 95% CI 6.44-31.12], Beers-listed PIMs [OR=8.19, 95% CI 3.01-22.28] and STOPP-listed PIMs [OR=8.21, 95% CI 3.47-19.44]. PIMs was the strongest predictor of PPOs [OR=2.79, 95% CI 1.81-4.28]. Conclusions: A high prevalence of polypharmacy and PIMs and PPOs were reported. More than half the patients had simultaneous PIMs and PPOs. The related factors to PIMs and PPOs were different. |
Note: | Versió postprint del document publicat a: http://dx.doi.org/10.1016/j.ejim.2014.07.011 |
It is part of: | European Journal Of Internal Medicine, 2014, vol. 25, num. 8, p. 710-716 |
URI: | https://hdl.handle.net/2445/68493 |
Related resource: | http://dx.doi.org/10.1016/j.ejim.2014.07.011 |
ISSN: | 0953-6205 |
Appears in Collections: | Articles publicats en revistes (Patologia i Terapèutica Experimental) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
648242.pdf | 124.28 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.